← Mechanisms of action
80S Ribosome
PROTEIN NUCLEIC-ACID COMPLEXHomo sapiens
Linked proteins
- 60S ribosomal protein L39 (RPL39) ↗
- 60S ribosomal protein L41 (RPL41) ↗
- 40S ribosomal protein S15 (RPS15) ↗
- 40S ribosomal protein S15a (RPS15A) ↗
- 40S ribosomal protein S16 (RPS16) ↗
- 40S ribosomal protein S17 (RPS17) ↗
- 40S ribosomal protein SA (RPSA) ↗
- 40S ribosomal protein S18 (RPS18) ↗
- 40S ribosomal protein S19 (RPS19) ↗
- 40S ribosomal protein S20 (RPS20) ↗
- 40S ribosomal protein S21 (RPS21) ↗
- 40S ribosomal protein S23 (RPS23) ↗
- 40S ribosomal protein S24 (RPS24) ↗
- 40S ribosomal protein S25 (RPS25) ↗
- 40S ribosomal protein S27 (RPS27) ↗
- 40S ribosomal protein S26 (RPS26) ↗
- Ubiquitin-40S ribosomal protein S27a (RPS27A) ↗
- 40S ribosomal protein S28 (RPS28) ↗
- 40S ribosomal protein S29 (RPS29) ↗
- 40S ribosomal protein S30 (RS30) ↗
- 60S ribosomal protein L21 (RPL21) ↗
- 60S ribosomal protein L22 (RPL22) ↗
- 60S ribosomal protein L23 (RPL23) ↗
- 60S ribosomal protein L23a (RPL23A) ↗
- 60S ribosomal protein L24 (RPL24) ↗
- 40S ribosomal protein S6 (RPS6) ↗
- 60S ribosomal protein L26 (RPL26) ↗
- 60S ribosomal protein L27 (RPL27) ↗
- 60S ribosomal protein L27a (RPL27A) ↗
- 60S ribosomal protein L28 (RPL28) ↗
- 60S ribosomal protein L29 (RPL29) ↗
- 60S ribosomal protein L30 (RPL30) ↗
- 60S ribosomal protein L31 (RPL31) ↗
- 60S ribosomal protein L32 (RPL32) ↗
- 60S ribosomal protein L34 (RPL34) ↗
- 60S ribosomal protein L35 (RPL35) ↗
- 60S ribosomal protein L35a (RPL35A) ↗
- 60S ribosomal protein L36 (RPL36) ↗
- 60S ribosomal protein L36a (RPL36A) ↗
- 60S ribosomal protein L37 (RPL37) ↗
- 40S ribosomal protein S10 (RPS10) ↗
- 40S ribosomal protein S11 (RPS11) ↗
- 40S ribosomal protein S12 (RPS12) ↗
- 40S ribosomal protein S13 (RPS13) ↗
- 40S ribosomal protein S14 (RPS14) ↗
- 60S ribosomal protein L37a (RPL37A) ↗
- 40S ribosomal protein S2 (RPS2) ↗
- 40S ribosomal protein S3 (RPS3) ↗
- 40S ribosomal protein S3a (RPS3A) ↗
- 40S ribosomal protein S4, X isoform (RPS4X) ↗
- 40S ribosomal protein S4, Y isoform 1 (RPS4Y1) ↗
- 40S ribosomal protein S5 (RPS5) ↗
- 40S ribosomal protein S7 (RPS7) ↗
- 40S ribosomal protein S8 (RPS8) ↗
- 40S ribosomal protein S9 (RPS9) ↗
- 60S ribosomal protein L3 (RPL3) ↗
- 60S ribosomal protein L4 (RPL4) ↗
- 60S ribosomal protein L5 (RPL5) ↗
- 60S ribosomal protein L6 (RPL6) ↗
- 60S ribosomal protein L7 (RPL7) ↗
- 60S ribosomal protein L7a (RPL7A) ↗
- 60S ribosomal protein L8 (RPL8) ↗
- 60S ribosomal protein L9 (RPL9; RPL9P7; RPL9P8; RPL9P9) ↗
- 60S ribosomal protein L10 (RPL10) ↗
- 60S ribosomal protein L10a (RPL10A) ↗
- 60S ribosomal protein L11 (RPL11) ↗
- 60S ribosomal protein L12 (RPL12) ↗
- 60S ribosomal protein L13 (RPL13) ↗
- 60S ribosomal protein L13a (RPL13A) ↗
- 60S ribosomal protein L14 (RPL14) ↗
- 60S ribosomal protein L15 (RPL15) ↗
- 60S ribosomal protein L17 (RPL17) ↗
- 60S ribosomal protein L18 (RPL18) ↗
- 60S ribosomal protein L18a (RPL18A) ↗
- 60S ribosomal protein L19 (RPL19) ↗
- 60S ribosomal protein L38 (RPL38) ↗
- 60S acidic ribosomal protein P0 (RPLP0) ↗
- 60S acidic ribosomal protein P1 (RPLP1) ↗
Drugs acting on this target (52)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| cemiplimab (libtayo) | Antagonist | approved | mAb | PD-1 |
| dorlimomab aritox | Binding agent | experimental | mAb | 80S Ribosome binding agent |
| 2B4.11 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| 609a | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| abbv-181 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| agen2034 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| ak105 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| ak111 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| amg 404 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| apl-501 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| bat1306 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| bi 754091 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| budigalimab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| cc-90006 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| cetrelimab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| cs1003 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| cx-188 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| cycloheximide | Inhibitor | experimental | Small molecule | 80S Ribosome inhibitor |
| dorlimomab aritox | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| dostarlimab (Jemperli) | Inhibitor | approved | mAb | 80S Ribosome inhibitor |
| durvalumab (imfinzi) | Inhibitor | approved | mAb | 80S Ribosome inhibitor |
| F520 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| genolimzumab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| geptanolimab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| gls-010 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| gnr-051 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| hlx10 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| hx008 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| incb106385 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| incmga00012 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| jtx-4014 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| ly3462817 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| lzm009 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| medi0680 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| mt-3724 | Inhibitor | experimental | Recombinant protein | 80S Ribosome inhibitor |
| nivolumab (opdivo) | Inhibitor | approved | mAb | 80S Ribosome inhibitor |
| oc-001 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| pembrolizumab (keytruda) | Inhibitor | approved | mAb | 80S Ribosome inhibitor |
| sasanlimab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| sct-i10 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| sg001 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| spartalizumab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| sym021 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| taplitumomab paptox | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| telimomab aritox | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| triprizumab | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| ty101 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| vb6-845 | Inhibitor | experimental | Recombinant protein | 80S Ribosome inhibitor |
| ybl-006 | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| zolimomab aritox | Inhibitor | experimental | mAb | 80S Ribosome inhibitor |
| ataluren (Translarna) | Modulator | experimental | Small molecule | 80S Ribosome modulator |
| elx-02 | Modulator | experimental | Small molecule | 80S Ribosome modulator |